MATTHEWS ASIA GROWTH FUND HKSE:01801 Holdings History
MATTHEWS ASIA GROWTH FUND's Innovent Biologics Inc Holding Summary
As of 2025-03-31, MATTHEWS INTERNATIONAL FUNDS held 432,000.00 shares of Innovent Biologics Inc(HKSE:01801), totaling HK$2.60 Mil. This investment constitutes 1.26% of their stock portfolio, and MATTHEWS INTERNATIONAL FUNDS now holds 0.03% of the outstanding Innovent Biologics Inc(HKSE:01801) stock.
The initial trade took place in 2019Q3. And since then MATTHEWS ASIA GROWTH FUND has made 4 purchases of HKSE:01801, at an average price of HK$27.59, for a total of 7.42 Mil shares. In addition, there have been 7 sales at an average price of HK$40.22 for 6.98 Mil shares. Based on historical transaction data and HKSE:01801's current price of HK$89.05, MATTHEWS ASIA GROWTH FUND's estimated gain on his HKSE:01801 holdings is HK$114.78 Mil, reflecting a 56.10% gain to date.
MATTHEWS ASIA GROWTH FUND HKSE:01801 (HK$89.05) Holding Chart
MATTHEWS ASIA GROWTH FUND HKSE:01801 (HK$89.05) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price HK$-/Share | ||
| Shares Sold | 0 | Average Price HK$-/Share | ||
| Current Price HK$0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
